Ipilimumab vs Tirzepatide

## Ipilimumab vs Tirzepatide: Overview

This comparison examines the pharmacological differences between **Ipilimumab** and **Tirzepatide**.

## Mechanism of Action

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

**Tirzepatide**: Dual GIP and GLP-1 receptor agonist.

## Pharmacokinetics

**Half-life**: Ipilimumab — 14.7 days; Tirzepatide — 5 days.

## Chemical Properties

**Type**: Ipilimumab — Antibody; Tirzepatide — Protein.